Cambridge Investment Research Advisors’s Morgan Stanley Emerging Mkts Fd MSF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-12,530
Closed -$202K 2385
2018
Q4
$202K Hold
12,530
﹤0.01% 1915
2018
Q3
$195K Buy
12,530
+890
+8% +$14.2K ﹤0.01% 2058
2018
Q2
$189K Sell
11,640
-140
-1% -$2.41K ﹤0.01% 2032
2018
Q1
$217K Sell
11,780
-160
-1% -$3.01K ﹤0.01% 1915
2017
Q4
$214K Buy
11,940
+1,010
+9% +$17.7K ﹤0.01% 1884
2017
Q3
$190K Buy
+10,930
New +$185K ﹤0.01% 1841
2013
Q3
Sell
-10,563
Closed -$151K 1240
2013
Q2
$151K Buy
+10,563
New +$163K 0.01% 1011

Other funds holding MSF

Cambridge Investment Research Advisors's MSF Position: Q1 2019 in Review

Cambridge Investment Research Advisors sold out of Morgan Stanley Emerging Mkts Fd (MSF) in Q1 2019, closing a stake of 12,530 shares — an estimated $202K sold.

Cambridge Investment Research Advisors first reported a position in MSF in Q2 2013 and held it in 7 quarters. The position peaked at $217K in Q1 2018. 1 fund tracked by Wall St. Rank holds MSF as of Q1 2019.

  • Cambridge Investment Research Advisors reported no remaining Morgan Stanley Emerging Mkts Fd position as of Q1 2019 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 12,530 Morgan Stanley Emerging Mkts Fd shares in Q1 2019, an estimated $202K.
  • Cambridge Investment Research Advisors first reported a position in Morgan Stanley Emerging Mkts Fd in Q2 2013 and held it in 7 quarters.
  • Cambridge Investment Research Advisors's Morgan Stanley Emerging Mkts Fd position peaked at $217K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Morgan Stanley Emerging Mkts Fd as of Q1 2019.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2019, filed 8 May 2019.